Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Researchers at Leiden University’s Institute of Biology have discovered that zebrafish exhibit distinct personality traits—proactive and reactive—that are genetically inherited. This finding, led by Assistant Professor Christian Tudorache, offers promising avenues for developing medications targeting mental health conditions such as ADHD and depression.
In the study, zebrafish were bred over multiple generations to emphasize their inherent behavioral tendencies. Proactive fish are characterized by risk-taking and aggressive behaviors, while reactive fish display cautiousness and heightened sensitivity to stress. These consistent traits across generations underscore the heritability of personality types in zebrafish.
The research holds significant implications for human mental health. Zebrafish share genetic similarities with humans, particularly in genes associated with neurodiversity. For instance, proactive zebrafish possess genes analogous to those linked to ADHD in humans, whereas reactive fish exhibit behaviors akin to depression, such as social withdrawal and increased stress sensitivity.
By utilizing these zebrafish models, scientists can more effectively test the efficacy of drugs intended to treat ADHD, depression, and bipolar disorder, potentially accelerating the development of targeted therapies.
For more information on this study, visit the Leiden University news article.
The Netherlands will host the NATO Summit on 24-25 June 2025 at the World Forum in The Hague, leading to significant traffic disruptions and security measures across the Randstad region from 22-26 June. Motorists can expect road closures on major routes, while public transport services will be adjusted, with certain trams and buses suspended, and travelers are advised to avoid the area or use alternative transportation options.
This summer, students and professionals passionate about pharmaceutical innovation have a unique opportunity to gain hands-on experience in modern drug development. The...
Leiden University researchers have developed the first-ever ‘dengue-on-a-chip’ model, using organ-on-a-chip technology to simulate the human body’s response to dengue infection, particularly focusing on hemorrhagic shock. This innovative tool offers a more ethical and cost-effective alternative to animal testing, aiding in the study of disease progression and the development of targeted treatments for the growing global health threat posed by dengue.